Plano Contact Lens Warning Indicates Continued FDA Regulation As Devices
This article was originally published in The Gray Sheet
Executive Summary
An FDA warning on the potential health risks of non-corrective (plano), decorative contact lenses signals that the products are unlikely to be regulated as cosmetics, as at least one manufacturer had hoped
You may also be interested in...
Plano Lens Cosmetics Classification Countered In Boozman-Waxman Bill
Legislation co-sponsored by Reps. Henry Waxman (D-Calif.) and House optometrist John Boozman (R-Ark.) targets alleged loopholes created by FDA's decision to regulate noncorrective contact lenses as cosmetics rather than medical devices
Plano Lens Cosmetics Classification Countered In Boozman-Waxman Bill
Legislation co-sponsored by Reps. Henry Waxman (D-Calif.) and House optometrist John Boozman (R-Ark.) targets alleged loopholes created by FDA's decision to regulate noncorrective contact lenses as cosmetics rather than medical devices
McClellan Outlines Vision For Device User Fees, Third-Party Inspections
Incoming FDA commissioner Mark McClellan, MD/PhD, is pledging to hold the agency to premarket review performance goals mandated under the "Medical Device User Fee and Modernization Act" if the bill becomes law